• Study of Olaparib for Patients with Advanced Cancer Having HRRm or HRD Mutations

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark France Ireland Italy Romania Spain
  • Study of Pembrolizumab and Chemotherapy for Patients with Triple Negative Breast Cancer

    Not recruiting

    3 1 1
    Investigated diseases:
    France Germany Ireland Italy Poland Portugal +2
  • Study on Long-Term Safety and Efficacy of Tildrakizumab for Adults with Psoriatic Arthritis

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Estonia Germany Italy Poland Slovakia +1
  • Study on the Effects of Pentosan Polysulfate Sodium for Knee Osteoarthritis Pain in Adults

    Not recruiting

    4 1 1
    Investigated diseases:
    Belgium Czechia Poland
  • Study on the Safety and Effectiveness of Sacituzumab Govitecan for Patients with Triple Negative Metastatic Breast Cancer

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France
  • Study of Venetoclax and Azacitidine for Adults 18+ with Acute Myeloid Leukemia Not Eligible for Standard Therapy

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany
  • Study of MK-1088 and Pembrolizumab for Patients with Advanced Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark
  • Study on Physical Activity and Joint Health in Patients Aged 12 and Older with Severe Hemophilia A Treated with Efanesoctocog Alfa for 24 Months

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Croatia Czechia France Germany +8
  • Study on the Safety and Effectiveness of CGT9486 for Patients with Nonadvanced Systemic Mastocytosis

    Not recruiting

    2 1
    Investigated diseases:
    Austria Belgium Czechia France Germany Greece +6
  • Study on Eptinezumab for Painful Diabetic Neuropathy in Adults

    Not recruiting

    2 1 1
    Investigated diseases:
    Denmark

powered by